ask="4.20"
ask_size="100"
average_daily_volume="32538"
bid="2.82"
bid_size="100"
book_value="0.49"
change="-0.06"
change_from_200_day_moving_average="-0.13"
change_from_50_day_moving_average="-0.07"
change_from_52_week_high="-6.35"
change_From_52_week_low="0.81"
change_in_percent="-1.63%"
close="3.62"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.42"
ebitda="-15.65M"
eps_estimate_current_year="-1.62"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-1.49"
ex_dividend_date="N/A"
float_shares="5720000"
high="3.79"
high_52_weeks="9.97"
last_trade_date="1/11/2017"
last_trade_price="3.62"
last_trade_size="100"
last_trade_time="3:59pm"
low="3.62"
low_52_weeks="2.81"
market_capitalization="30.33M"
moving_average_200_day="3.75"
moving_average_50_day="3.69"
name="VistaGen Therapeutics
Inc."
notes="N/A"
one_year_target_price="23.50"
open="3.65"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-3.38%"
percent_change_from_50_day_moving_average="-1.91%"
percent_change_from_52_week_high="-63.69%"
percent_change_from_52_week_low="+28.83%"
previous_close="3.68"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.45"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="8379000"
short_ratio="2.67"
stock_exchange="NCM"
symbol="VTGN"
volume="25312"
weeks_range_52="2.81 - 9.97"
